Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

[Intra-uterine growth restriction impact on maternal serum concentration of PlGF (placental growth factor): A case control study].

Margossian A, Boisson-Gaudin C, Subtil F, Rudigoz RC, Dubernard G, Allias F, Huissoud C.

Gynecol Obstet Fertil. 2016 Jan;44(1):23-8. doi: 10.1016/j.gyobfe.2015.11.005. Epub 2015 Dec 24. French.

PMID:
26725205
2.

Progesterone receptor isoform-specific promoter methylation: association of PRA promoter methylation with worse outcome in breast cancer patients.

Pathiraja TN, Shetty PB, Jelinek J, He R, Hartmaier R, Margossian AL, Hilsenbeck SG, Issa JP, Oesterreich S.

Clin Cancer Res. 2011 Jun 15;17(12):4177-86. doi: 10.1158/1078-0432.CCR-10-2950. Epub 2011 Apr 1.

3.

DNA methylation as a biomarker in breast cancer.

Martens JW, Margossian AL, Schmitt M, Foekens J, Harbeck N.

Future Oncol. 2009 Oct;5(8):1245-56. doi: 10.2217/fon.09.89. Review.

PMID:
19852739
4.

Multicenter study using paraffin-embedded tumor tissue testing PITX2 DNA methylation as a marker for outcome prediction in tamoxifen-treated, node-negative breast cancer patients.

Harbeck N, Nimmrich I, Hartmann A, Ross JS, Cufer T, Grützmann R, Kristiansen G, Paradiso A, Hartmann O, Margossian A, Martens J, Schwope I, Lukas A, Müller V, Milde-Langosch K, Nährig J, Foekens J, Maier S, Schmitt M, Lesche R.

J Clin Oncol. 2008 Nov 1;26(31):5036-42. doi: 10.1200/JCO.2007.14.1697. Epub 2008 Aug 18.

PMID:
18711169

Supplemental Content

Loading ...
Support Center